All Industries

Benchmark International Successfully Facilitated the Transaction Between D TEL Telecommunications, Inc. and Responsive Technology Partners

Benchmark International

Benchmark International has successfully facilitated a transaction between Gastonia, NC-based D TEL Telecommunications, Inc. (D TEL) and Atlanta, GA-based Responsive Technology Partners (RTP). D TEL is a systems integrator that distributes and installs premise, hybrid, and cloud-based phone systems, paging, surveillance, access control, and sound systems. D TEL additionally offers dial tone brokering and wholesales telecom products. Founded in 1984, D TEL has been serving the small and midsize business (SMB) sector, focusing on the healthcare, medical, manufacturing, and service industries in North and South Carolina for 40 years. Responsive Technology Partners provides IT support services throughout North Carolina, Virginia, Georgia, Florida, and other US customers. They are a major leader in the MSP industry, having achieved growth both organically and by acquisition means. RTP offers services that include IT support, cybersecurity and compliance, telephony, cloud services, cabling, access control, and camera systems. "The entire Benchmark team is exceedingly pleased with this great new partnership between D TEL Telecommunications and Responsive Technology Partners," commented Benchmark Senior Transaction Director William Sullivan. "D TEL President Jim LaBrec and his team have done an outstanding job building and positioning their great company in a very attractive market. We believe that RTP will be a great steward of D TEL's storied legacy, and we wish the combined team all the best moving forward." ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

October 01, 2024 10:54 AM Eastern Daylight Time

Image

Velocity Global Named a Leader in NelsonHall’s Global Employer of Record (EOR) Evaluation for the Fourth Time in a Row

Velocity Global

Velocity Global, the world’s expert on work, announced today that it was positioned as a leader in the 2024 Vendor Evaluation & Assessment Tool (NEAT) for global EOR services by NelsonHall. The report recognizes Velocity Global for both its ability to deliver immediate customer benefits as well as its capabilities to meet future customer needs. This marks the fourth time in a row that Velocity Global has earned this distinction, solidifying its position as a trusted partner for companies expanding their global presence. "Deploying a global workforce is extremely complex, as companies need to navigate a maze of varying regulations, compliance needs, and talent expectations in different countries," said Jeanine Crane-Thompson, Principal Analyst at NelsonHall’s HR & Talent Transformation practice. "Velocity Global’s blend of strategic R&D investments and compliance expertise has transformed them into a critical partner for companies looking to accelerate global growth. Their comprehensive EOR solution allows organizations to focus on their expansion goals without the burden and potential risks of logistical and legal complexities." As a trailblazer in global workforce solutions, Velocity Global empowers companies to hire, manage, pay, and retain talent, anywhere in the world. Over the years, Velocity Global has evolved from offering a point solution to being a strategic partner to its customers as they execute on their global growth plans. Velocity Global’s powerful combination of its self-service Global Work Platform and its deep legal and HR expertise ensures seamless compliance, no matter how complex the jurisdiction. Both employers and employees benefit from a frictionless, user-friendly experience. In its 2024 report, NelsonHall highlights several strengths that contributed to Velocity Global’s positioning as a leader, including: Mature EOR market provider: Velocity Global offers a compliant, integrated EOR solution that enables multinational companies to confidently hire across borders. Technology roadmap: Velocity Global’s roadmap is centered on AI-driven enhancements, expanded platform integrations, and robust self-service functionality. Competitive service offerings beyond EOR: Velocity Global offers an array of services beyond EOR, including global benefits, immigration support, pensions, equity management, and office space logistics. ”The ability to hire anyone, anywhere is a huge differentiator as companies expand across geographies and tap into underutilized talent pools,” says Francoise Brougher, CEO of Velocity Global. “To simplify and streamline this process for customers, we invest in our technology. This, coupled with our extensive in-country and compliance expertise, means customers can have peace of mind and focus on growing their business.” This latest recognition reinforces Velocity Global’s unwavering commitment to empowering businesses with the tools and expertise to navigate the complexities of the global workforce landscape and drive sustained growth. To learn more about what sets us apart, download the report [ here ]. For more information on how Velocity Global makes opportunity borderless for people everywhere, visit www.velocityglobal.com. About Velocity Global Velocity Global gives you the power to build your team everywhere—combining seamless technology and local expertise in 185+ countries. We make it simple to compliantly hire, pay, manage, and retain talent anywhere. With Velocity Global, the world is yours. About NelsonHall NelsonHall is the leading global analyst firm dedicated to helping organizations understand the 'art of the possible' in digital operations transformation. With analysts in the U.S., U.K., Continental Europe, and Asia, NelsonHall provides buy-side organizations with detailed, critical information on markets and vendors (including NEAT assessments) that helps them make fast and highly informed sourcing decisions. And, for vendors, NelsonHall provides deep knowledge of market dynamics and user requirements to help them hone their go-to-market strategies. NelsonHall's analysis is based on rigorous, primary research, and is widely respected for the quality and depth of its insight. Media Contact: press@velocityglobal.com Contact Details Media contact +1 720-650-4348 press@velocityglobal.com Company Website https://velocityglobal.com/

October 01, 2024 07:47 AM Pacific Daylight Time

Image

How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit

Benzinga

By James Blacker, Benzinga Global healthcare group Cosmos Health (NASDAQ: COSM) has potentially positioned itself for growth through its acquisition last year of Cana Laboratories, a Greek pharmaceutical company with nearly a century of expertise. As Cosmos’ new manufacturing arm, Cana brings a wealth of synergies, potentially enabling the company to control its own production, from pharmaceuticals to nutraceuticals. Cana Laboratories: A Century Of Expertise Founded in 1928, Cana Laboratories has earned its name in the pharmaceutical industry over nearly a century, having partnered with companies such as AstraZeneca (NASDAQ: AZN), Merck (NYSE: MRK), Janssen, Nestlé (OTC: NSRGY), Unilever (Unilever), Viatris (NASDAQ: VTRS) and Procter & Gamble (NYSE: PG). In recent years it has also worked with major firms in the medtech space, namely Medtronic (NYSE: MDT) and Stryker (NYSE: SYK). Cosmos acquired Cana in July of last year for around $1.67 million – a heavy discount compared to Cana’s $10 million valuation at the time, according to the company. As such, Cosmos expects to record a substantial gain on the purchase of what it now considers to be its crown jewel asset. The acquisition of Cana equips Cosmos with in-house manufacturing capabilities, bringing significant vertical integration and providing greater control over quality and costs. Cosmos can now use Cana’s facilities to manufacture its portfolio of generic medicines, including treatments for diabetes, cholesterol, respiratory and cardiac conditions, as well as its proprietary nutraceutical brand, Sky Premium Life. The acquisition has moreover added several brands to Cosmos’ portfolio, including antiseptics like C-Sept, the organic infant care line biobebe and dermocosmetics such as Eleon Cosmetics. New Facility To Scale Production Furthermore, Cosmos now owns Cana's 54,000 sq. ft. production facility in Athens. Certified by the European Medicines Agency and with a Good Manufacturing Practice license, this facility enhances Cosmos’ production capabilities, creating opportunities for potentially lucrative contract manufacturing agreements. Cosmos has invested some $5.5 million in Cana since the acquisition. The investment includes upgrading the Athens facility with new machinery, equipment, IT infrastructure and quality management systems. These investments will enable the company to manufacture a wide range of pharmaceuticals at scale, such as tablets, capsules, syrups, sprays, creams, gels and ointments. The company announced in July this year that it completed the first phase of this upgrade. At full capacity, which Cosmos says will be reached by the end of 2025, the facility is expected to generate over $10 million in annual gross profit. This stands in contrast to Cosmos’ current market cap of about $15 million as of Sept. 27. Contract Manufacturing: A High-Margin Growth Driver With its enhanced manufacturing capacity, Cosmos aims to accelerate the growth of its contract manufacturing business. In July, the company announced that it signed agreements with Provident Pharmaceuticals and Humacology to manufacture 5,020,000 units of medicines and up to 500,000 CBD units. Cosmos says its contract manufacturing business has very high margins thanks to minimal costs, most of which are borne by clients. The company, therefore, expects the newly signed deals to be highly profitable. Moreover, with less than 20% of its production capacity being utilized, there is plenty of room to sign additional contracts. Further down the line, if the facility reaches full capacity, Cosmos is prepared to initiate a second phase of the expansion to further boost capacity and gross profits beyond the projected $10 million from phase 1. Cosmos Health says it is confident that the acquisition of Cana Laboratories positions it for substantial growth. With its new in-house production capabilities, the company can boost efficiency and secure high-margin contract manufacturing agreements. Interested investors may want to watch for announcements of further contract manufacturing agreements as Cosmos seeks to fully utilize its production capacity. Featured photo by Testalize.me on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 01, 2024 09:30 AM Eastern Daylight Time

Image

Canoo’s Oklahoma Plant Becomes First Automotive Foreign-Trade Zone In The State, Cutting Red Tape And Reducing Fees

Benzinga

By Meg Flippin, Benzinga Canoo Inc. (NASDAQ: GOEV), the high-tech advanced mobility company churning out fully electric lifestyle vehicles, just got the final nod from the U.S. Customs and Border Protection (CBP) for its Oklahoma City operations to become the first automotive Foreign-Trade Zone in the state. Foreign-Trade Zones (FTZs) are specially designated sites close to U.S. ports that importers and exporters use to move goods in and out of the country. Companies operating in FTZs pay reduced or zero duties, taxes or fees. FTZs help U.S. companies to compete better on the global stage by streamlining logistics, minimizing regulatory hurdles and better controlling inventory. Perks offered for being In Oklahoma City’s FTZ include duty elimination on previously imported material, materials that are re-exported, rejected, scrapped, wasted or return-to-vendor imported material and sales of imported materials or finished products containing imported components to companies operating in other U.S. FTZs. Duties are deferred for manufacturing in the U.S. and selling domestically. Other perks include just-in-time delivery, quotas and reduced customs delays, as well as the ability to hold merchandise in a foreign-trade zone indefinitely. Canoo Bolsters Oklahoma Plant Canoo’s Oklahoma plant, which the company opened last April, occupies close to 500,000 square feet, with the ability to expand, and can employ over 500 people at capacity! Canoo recently added to the Oklahoma plant’s occupancy by migrating its engineering workforce from California to the state. Canoo said one of the main reasons for the move to Oklahoma is to have engineering and manufacturing under one roof. The company said the strategic decision will “drive operational efficiencies and foster greater collaboration as Canoo continues to meet goals towards its step level ramp manufacturing.” That’s becoming a reality thanks in part to its two tranches of new or like-new advanced manufacturing assets, formerly owned by Arrival Automotive UK Limited, at its facility in Oklahoma City. The received assets will bolster in-house processes and enable higher cabin line production volumes in 2025, the company said. “We thank Oklahoma City Customs Port Director Pequano and the Dallas U.S. Customs and Border Protection Area Port office for the work, support and direction for the activation approval. It's great to get this milestone completed as it's part of a larger strategy with more to come,” said Tony Aquila, Investor, Executive Chairman and CEO of Canoo. The company said the FTZ is a big deal toward “harmonizing” its supply chain and protecting it from the whims of other countries. Being in the FTZ also provides stability against a tariff landscape that has the potential to change in 2025. Reimaging Fully Electric Vehicles Canoo makes a suite of fully electric delivery vehicles (LDVs) that are built on a modular design. The modular electric platform is designed to maximize vehicle interior space, enabling it to be customizable across owners and applications. With a robust lineup of electric LDVs, including delivery vehicles, pickup and lifestyle vehicle (LV), Canoo is attempting to do to the commercial transportation market what Tesla (NASDAQ: TSLA) did to the consumer EV market with its lineup of sedans, SUV and truck. It doesn’t hurt that Canoo makes its LDVs with what it says are eco-friendly materials with the smallest footprint. Canoo’s delivery vehicles are designed to be modular, built for global roads and a variety of commercial uses. Canoo is focused on driving value for fleets by reducing total cost of ownership and maximizing utilization through software solutions and customized upfitting. It also sticks to a clean, minimalist shape that has gotten recognition, most recently receiving several Red Dot Design Awards. The Red Dot Award is an annual international competition recognizing excellence in design and among the world’s largest design competitions, validating Canoo’s approach to design. Learn more about Canoo Inc. by checking out its investors website here. Featured photo courtesy of Canoo. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 01, 2024 09:25 AM Eastern Daylight Time

Image

Forum Health Launches Revolutionary PNOĒ Metabolic Device Transforming Weight Management, Fitness and Longevity

Forum Health

Forum Health, a premier provider of personalized integrative and functional medicine, announces the launch of the PNOĒ metabolic analysis device, offering precise insights into metabolic, heart, lung, and cellular health for personalized wellness. Now available in Forum Health’s Madison and Fond du Lac, Wisconsin clinics, the PNOĒ uses a data-driven approach to weight management, fitness, and longevity optimization. Schedule a PNOĒ assessment here: Fond du Lac or Madison. Julie Heyrman, MD: "We’re thrilled to bring this advanced technology to our patients in Wisconsin. The PNOĒ allows us to better tailor health solutions that address the root causes of weight gain, fatigue, aging, and cardiovascular risk." Through using only breath, the PNOĒ provides a comprehensive metabolic analysis on how effectively the body burns calories, the efficiency of the heart and lungs, and overall cellular performance. Patients receive personalized health plans tailored to their unique metabolic profile for improved wellness and disease prevention. Key Benefits of PNOĒ Metabolic Analysis: Precision Weight Management: Analyzes metabolism to optimize workouts, calorie intake, and macronutrient balance for sustainable weight management. Endurance Enhancement: Measures the efficiency of heart, lungs, and cells, identifying limiting factors and providing a customized plan to overcome them. Longevity Optimization: Calculates VO2 max, cellular health, and metabolic efficiency—key predictors of lifespan and well-being. Early Detection - Detects early risk factors for heart, lung, and metabolic conditions, empowering proactive health steps. Phil Hagerman, CEO: “Forum Health is committed to bringing the most advanced technologies to our patients, and the PNOĒ device represents a new frontier in personalized healthcare. By offering precise metabolic insights, we can create tailored health plans that drive better outcomes for the health issues most affecting our patient's overall well-being.” About PNOĒ PNOĒ is a state-of-the-art metabolic analysis device that provides comprehensive assessments of heart, lung, and cellular fitness through breath analysis. Learn more at pnoe.com. About Forum Health, LLC Forum Health, LLC is a nationwide provider of personalized healthcare steeped in the powerful principles of functional and integrative medicine. Our providers take a root-cause approach to care exploring lifestyle, environment, and genetics to help each patient achieve their ultimate health goals. Members have access to advanced medical treatments and technology, with care plans informed by data analytics and collaborative relationships. For more, visit www.forumhealth.com. Contact Details Britt Wittelsberger +1 410-852-0738 bwittelsberger@forumhealth.com Company Website https://forumhealth.com

October 01, 2024 08:50 AM Eastern Daylight Time

COLORESCIENCE® INTRODUCES TOTAL LASH™ MASCARA

Colorescience

Colorescience®, a leading dermatologist-recommended specialty skincare company, is launching Total Lash™ Mascara, an innovative, new all-in-one lash serum, conditioner and mascara that immediately enhances the appearance of lash length and volume for a vibrant, eye-opening effect. With every application, this clinically tested formula works to improve lash health with a blend of peptides and botanicals that nourishes the lashes while helping support the natural lash cycle for healthier, stronger, fuller and longer looking lashes. The Total Lash™ ingredient complex uses gentle, prostaglandin analogue-free ingredients and has been ophthalmology tested and confirmed to be safe for sensitive eyes and contact lens wearers. This formula is ideal for those who want to restore and improve their natural lashes, especially after discontinuing lash extensions, false lashes, or other lash procedures. Dr.Tanya Khan, Oculoplastic Surgeon and Board-Certified Ophthalmologist, led the clinical study. After a 12-week clinical trial with daily usage of Total Lash Mascara 90% of subjects reported their lashes looked longer. As measured by Dr. Khan, lashes were on average 24% longer compared to baseline. Over 92% of subjects reported less lash breakage and 94% reported lashes appeared fuller, thicker, and fluffier after twelve weeks of usage. Recalling these results, Dr. Khan shared, “During the clinical study, it became clear to me that patients were readily achieving their desired results of lash growth, density, thickness, and darkness when using the Total Lash™ product once per day. As an oculoplastic surgeon and ophthalmologist, I am even more amazed that the formula is well-tolerated by sensitive eyes and does not cause irritation or discoloration of the delicate skin around the eye area. I look forward to offering this product to my patients as a safe, effective, and gentle daily option that delivers lash enhancement without prostaglandins or extensions.” This multi-benefit formula enhances the appearance of length and volume, nourishes and strengthens the lashes and supports lash growth. Proven peptide Myristoyl Pentapeptide-17 stimulates the hair follicle to help support continued growth while botanical extracts optimize root health and help promote continued growth for longer, fuller looking lashes. The results are a visibly denser, more defined lash line and longer lashes that are hydrated and nourished. Panthenol and jojoba seed oil condition and nourish lashes to reduce breakage helping strengthen and prolong length and volume. Lastly, the formula immediately enhances lashes upon application while providing all-day smudge-free wear. This tubing mascara wraps each lash in a rich black iron oxide mineral pigment, making this dye-free formula ideal for sensitive eyes. Patricia Boland, VP of Research & Development at Colorescience says, “We created this formula with the tubing feature because our goal is always to treat and improve while delivering immediate enhancement and optimal wear. The skin around the eyes is especially thin and delicate, so extensive rubbing during removal of products can contribute to irritation. Instead, our Total Lash Mascara envelops each lash with our clinically proven treatment complex while maximizing wear-time, and the product removes effortlessly with warm water and a favorite cleanser.” ABOUT COLORESCIENCE Colorescience ®, the leading innovator in all-mineral sun protection, delivers transformational skincare solutions through wearable multifunctional products that provide immediate confidence and long-term visible results. Crafted for users who know that great results require daily skincare and protection, Colorescience ® uses cutting-edge technology and clinically tested formulas to ensure efficacy and provide reassurance to people of all ages, skin types, and concerns. Colorescience ® products speak for themselves through their wearability, published clinical studies, and skin-healthy ingredients. For more information please contact: Project MM, meredith@projectmmnyc.com Contact Details Meredith Winfrey meredith@projectmmnyc.com Company Website https://www.colorescience.com

October 01, 2024 08:00 AM Eastern Daylight Time

October Issue of News Direct PRevolution Newsletter Lands on October 1

News Direct

Here are some of the topics News Direct tackles in the upcoming issue of PRevolution: AI Misfire Leads to Viral PR Recovery We highlight one of the year's most bizarre PR events in which a major tech company attempted to automate an entire PR campaign using AI, but the results were more comical than cutting-edge. The incident serves as a reminder of the potential pitfalls of AI in PR and the importance of adaptability during a crisis. Navigating the Political Center: A PR Strategy for Moderates With election season approaching and political divisions more visible than ever, PRevolution explores how a centrist independent presidential candidate might successfully run a campaign. In a hypothetical scenario, we make suggestions about the strategies such a candidate would need to employ to connect with the presumably enormous political middle in the U.S. PR in Baseball and Politics Intersect in November In somewhat of an historical anomaly, we examine the convergence of two major events—Game 4 of the World Series and Election Day, which occur just days apart this year. Taking inspiration from both the political and sports arenas, we identified the PR firms excelling in each. Top PR Performers of 2024’s First Half We recognize the PR firms that delivered outstanding financial performance in the first half of 2024. We found a mixed bag of small, medium and large agencies that enjoyed a hot first half. CEO’s Monthly Thoughts on Key PR Topics Continuing with the Post-Season baseball theme, News Direct CEO and founder Gregg Castano’s October editorial addresses the PR impact of Major League Baseball's increasing shift to paid streaming services for game broadcasts. While streaming offers convenience and attracts younger, tech-savvy viewers, Castano warns that this strategy risks alienating MLB's core fanbase. These articles and more are featured in the October 2024 edition of "PRevolution," keeping you informed on the latest trends, strategies, and lessons from the PR world. About News Direct News Direct is a technology-driven content distribution and amplification platform for PR, IR, corporate communications and marketing professionals. Our automated platform delivers a completely reimagined, modernized user experience for newswire users that has reshaped the industry landscape. Additionally, the company has expanded its offerings to include an array of technology-enhanced message amplification tools ranging from sponsored content to podcasting products, all from a single online destination. Contact Details Media at News Direct +1 917-698-4131 media@newsdirect.com Company Website http://www.newsdirect.com

September 30, 2024 09:03 AM Eastern Daylight Time

Image

AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances

Wall Street Reporter

NEW YORK, September 30, 2024 -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: iQIYI (NASDAQ: IQ), New World Solutions (OTC: REGRF) (CSE: NEWS), Tonix Pharmaceuticals (NASDAQ: TNXP), and Artificial Intelligence Technology Solutions (OTC: AITX). Wall Street Reporter highlights the latest comments from industry thought leaders shaping our world today, and in the decades ahead: New World Solutions (OTC: REGRF) (CSE: NEWS) Chairman Jack Marks: ”...Pure Play on $31 Billion Luxury Watch Market” New World Solutions (OTC: REGRF) (CSE: NEWS), majority-owned dialMKT is addressing the digital transformation of the multi-billion dollar global wristwatch enthusiast market by developing a digital ecosystem integrating content, e-commerce, and community.dialMKT’s e-commerce platform is expected to go live within 30 days. The global pre-owned watch market for luxury brands such as Rolex(™), and Patek Philippe(™), is expected to reach $29-32 billion by 2025, according to a recent report from McKinsey & Co. dialMKT CEO and New World Chairman Jack Marks commented “dialMKT already has a fast-growing online community of almost +18,000 users across its website and social media channels, including, YouTube, Instagram, and a growing e-mail newsletter. From our interactions with our community, we know many of these enthusiasts have watch collections worth $50,000 to well over $1 million+. Our business model anticipates that a significant number of our community members will turn into customers on our e-commerce platform to buy, sell and trade their collections - a pipeline for potentially significant revenues in the months ahead". Marks, further noted that (OTC: REGRF) (CSE: NEWS) is “the first and only “pure play” stock focused on the multibillion dollar watch enthusiast market.” Validating the investment thesis of the digital transformation of the watch market, venture capital is flowing into online watch market platforms such as Chrono24, and attracting investors such as Bill Ackman, Jay Z, Tom Brady, Mike Ovitz, Bernard Arnault, Google Ventures and others. New World Solution (OTC: REGRF) (CSE: NEWS) News: https://www.wallstreetreporter.com/2024/09/18/new-world-solutions-cse-news-enters-31-billion-global-watch-market-with-acquisition-of-majority-stake-in-dialmkt/ iQIYI (NASDAQ: IQ) CEO Yu Gong: “Dedicated to Premium Production and Harnessing AI”. iQIYI (NASDAQ: IQ) China's leading online entertainment platform, announced the upcoming release of over 300 new titles across diverse genres over the next year, at its iJOY Conference held in Shanghai. The company highlighted its strategic expansion into short dramas, introducing content that leverages the growing global popularity of Chinese content while utilizing innovative AI to navigate emerging industry trends. Yu Gong stated, "These offerings are not just low-budget online series; they continue to reflect our dedication to premium production and creativity. While many companies allocate over 90% of their revenue to promoting the content, iQIYI directs more than 70% back to content producers." Gong also shared how the company is leveraging AI to transform traditional content distribution methods and enhance interactions between users and machines, creating a more emotionally resonant experience. iQIYI (NASDAQ: IQ) News: https://www.wallstreetreporter.com/2024/09/26/iqiyi-nasdaq-iqunveils-over-300-new-titles-at-the-2024-ijoy-conference-adding-focus-on-short-dramas-to-accelerate-growth/ Artificial Intelligence Technology Solutions (OTC: AITX) Steve Reinharz CEO: “RADCam is Transformative Technology Offering Unparalleled Level of Engagement” Artificial Intelligence Technology Solutions (OTC: AITX) announcd that RAD-R, its subsidiary, is now accepting online preorders for the groundbreaking RADCam™ at radcam.ai. Described as the world’s first AI-powered, purpose-built ’Talking Security Camera’, it is designed to engage with individuals approaching or entering homes, Shipments are expected to begin in mid-December 2024. Steve Reinharz, CEO/CTO of AITX and RAD-R, commented, “RADCam is not just another security camera, it’s a transformative technology. By utilizing our proprietary AIR™ technology, RADCam offers homeowners and small businesses an unparalleled level of engagement and protection that traditional cameras simply can’t match.” Building on the success of its primary subsidiary, Robotic Assistance Devices, Inc. (RAD), AITX has proven that direct interaction with individuals engaged in or considering suspicious activities can deter potential threats. Artificial Intelligence Technology Solutions (OTC: AITX) News: https://www.wallstreetreporter.com/2024/09/24/aitxs-otc-aitx-subsidiary-rad-r-now-accepting-radcam-preorders-online/ Tonix Pharmaceuticals (NASDAQ: TNXP) “Zembrace ® is Compelling Non-Oral Option For Treating Migraines” Tonix Pharmaceuticals (NASDAQ: TNXP) a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced issuance of a US patent No. 12,097,183 entitled “Pharmaceutical Composition for Treating Migraine”, claims use of a pre-filled autoinjector comprising a composition of Zembrace ® SymTouch ® for treating migraines via subcutaneous administration. This patent, excluding possible patent term extensions, is expected to provide protection into 2036. “We are excited to announce the issuance of this additional patent, providing additional protection for our exclusive marketing and sale of FDA-approved Zembrace ® for the treatment of migraines,” said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. “We believe Zembrace ® is a compelling non-oral option for people who suffer with migraines.” Tonix Pharmaceuticals (NASDAQ: TNXP) News: https://www.wallstreetreporter.com/2024/09/27/tonix-pharmaceuticals-announces-issuance-of-u-s-patent-covering-the-subcutaneous-delivery-of-fda-approved-zembrace-symtouch-to-treat-migraines/ WALL STREET REPORTER Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com. Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Issuer sponsored content in this article includes: New World Solutions. Full disclaimer, and relevant SEC 17B disclosures here: https://tinyurl.com/2x4eznd5 About Wall Street Reporter’s Next Super Stock conference: Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/ CONTACT: WALL STREET REPORTER (212) 871-2057 ext 7 www.WallStreetReporter.com Rolex (™), Patek Philippe (™), Audemars Piguet (™), Cartier (™) Frank Muller (™) and Richard Mille (™) are licensed trademarks of their respective owners. dialMKT is not an authorized dealer or has any commercial relationship with these brands. Contact Details Wall Street Reporter John Rogers +1 212-871-2057 news@wallstreetreporter.com

September 30, 2024 09:00 AM Eastern Daylight Time

Could Lithium Prices Be Near The Bottom Of The Cycle? This Company Believes So – A Look At How Li-FT Power Stacks Up

Benzinga

By Anthony Termini, Benzinga Learn more about Li-FT Power’s journey to becoming “The Fastest Developing North American Lithium Junior” Miner here! Batteries are an indispensable power source globally. They keep smartphones, tablets and computers running. They help move electricity through the nation’s power grid. Furthermore, their role is expected to continue to grow as they are a critical component of electric and hybrid vehicles. Grand View Research estimates that battery sales worldwide totaled $118.2 billion in 2023 and will grow at a CAGR of 16.1% through 2030. That will have an impact on the raw materials that go into them, including lithium, which is a key element in EV batteries; McKinsey predicts that the lithium-ion battery chain from mining to recycling could grow at over 30% over 2022-2030. What Wall Street Says About Lithium Prices There are a lot of ingredients that go into batteries. One of the most significant today is lithium. Lithium is the highly reactive metal that, for all intents and purposes, gives a battery its electric charge. Demand for the commodity metal has been sluggish lately. The International Energy Agency (IEA) notes that demand projections outweigh available global supply only marginally and the agency predicts that this isn’t likely to change for at least the next few years. While limited demand may have contributed to the nearly 75% decline in the price of lithium in the last two years, some believe that a rebound is in the offing. Investment firm Goldman Sachs says that their “ long-term demand estimates have risen.” Goldman rival, Morgan Stanley, says that “to meet global net-zero goals by 2040, lithium demand alone would grow by more than 40 times.” The net result, say analysts at JP Morgan is that “market participants may underestimate the sustainability of mining company earnings and cash flows.” One company positioning itself to benefit from any rebound in lithium prices is Vancouver, Canada-based Li-FT Power (OTC: LIFFF). How Li-FT Might Benefit From Future Changes In Lithium Prices Li-FT is a mineral exploration company engaged in the acquisition, exploration and development of lithium. The company’s flagship property is the Yellowknife Lithium and Cali Lithium Project located in the Northwest Territories. Li-FT also owns three potential mining sites in Quebec province. The company’s portfolio of hard rock lithium assets is in early-stage development. Li-FT has conducted initial drill tests to define existing mineral resources, and at one site, targets for discovery drilling are in the process of being identified. The Yellowknife project may be Li-FT’s most promising mine when it goes into production. The company reports that outcrops of the base material that contains lithium (spodumene) are so prominent that they can be seen even in satellite imagery. Prospecting and mapping in the summer of 2023 defined a number of areas where significant levels of spodumene are likely to exist, the company said. Francis MacDonald, Li-FT’s CEO, says that Yellowknife “is a tremendous opportunity” and that it has “the potential to be one of the largest hard rock lithium resources in North America.” Tests of core samples from Yellowknife indicate that their host mineral is predominantly spodumene, which can hold a theoretical lithium content – or grade – of 8.03%. Metallurgical testing of samples taken prior to Li-FT’s acquisition of Yellowknife showed a lithium concentration between 5% and 6%. Those earlier tests revealed that lithium could be produced at an overall recovery of 80%. This is the proportion of valuable material extracted during processing. Metallurgical testing is ongoing and Li-FT expects to have its own preliminary results before the end of 2024. These promising results compare very favorably to Li-FT’s peers that are either currently in production or at the preliminary economic assessment stage of their projects, according to data compiled by the company. Those companies have published results showing lithium grades between 1.24% and 1.4%. In terms of market capitalization, Li-FT’s market capitalization of close to $100 million compares to Sigma Lithium’s (NASDAQ: SGML) over $1 billion and Latin Resources’ (OTC: LRSRF) $378 million (as of Sep. 11). Li-FT expects to release its first mineral resource estimates in the fourth quarter of 2024. A Long History Of Discovery, M&A And Mine-Building Experience Li-FT acquired the Yellowknife Lithium Project in a merger with a private company in 2022 and the company is led by an experienced team of mining professionals with a long track record in the industry. Mining industry veteran Francis MacDonald is the company’s CEO and a member of its board of directors. MacDonald is an alumnus of Newmont Corporation (NYSE: NEM), one of the world’s largest gold mining companies, where he specialized in finding and assessing early exploration stage projects. Li-FT’s President is Alex Langer, a former investment banker focused on the mining and technology sectors at Canaccord Genuity (TSX: CF). Langer is the CEO & President of Sierra Madre Gold & Silver (TSXV: SM). He is also a member of Li-FT’s board. The company's CFO, Andrew Marshall, is also a mining industry veteran. He is a CFO at Pan Global Resources (NASDAQ: PGZFF) and previously held the position of CFO at First Mining Gold (NASDAQ: FFMGF). April Hayward, the company's Chief Sustainability Officer, is responsible for executive oversight of Li-FT’s Environmental, Social and Governance (ESG) efforts. She brings vast experience in corporate responsibility from her time at Ekati Diamond and Mountain Province Diamonds (TSX: MPVD). Highlights Of Li-FT’s Focused ESG Commitment Mining lithium has an environmental impact and may affect the socio-economic well-being of the communities where operations take place. These are some of the issues Li-FT’s Hayward is tasked to mitigate. Baseline environmental and socio-economic data collection began in June 2023 and Li-FT expects to begin an initial environmental assessment in 2025. The company maintains strong, collaborative relationships with local indigenous groups in the area and has prioritized hiring and procurement policies centered around them. For example, more than 28% of the work performed at the Yellowknife Lithium Project goes to indigenous employees. The company reports that in 2023, the project channeled some $2.4 million in spending to these local groups. In June 2023, Li-FT engaged archaeology crews to survey the project with members of local indigenous communities. How Investors Might View Li-FT Li-FT is still in the early stages of exploration. Initial results seem promising, but there are still a lot of unknowns. From an investment perspective, Li-FT may be one to watch as changes in lithium pricing unfold over the next few years. Like all commodities, lithium prices exhibit a cyclical nature. While they are now a little higher than where they were a year ago, Li-FT believes that they are closer to this cycle’s bottom than its top. For patient investors with an eye on the future, potential beneficiaries of a lithium rebound like Li-FT may be worth watching. Interested investors can start here to learn more. Featured photo by MiningWatch Portugal on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 30, 2024 08:30 AM Eastern Daylight Time

Image

1 ... 37 38 39 40 41 ... 3764